Financhill
Sell
49

MZDAY Quote, Financials, Valuation and Earnings

Last price:
$3.11
Seasonality move :
2.21%
Day range:
$3.02 - $3.15
52-week range:
$3.02 - $6.52
Dividend yield:
6.18%
P/E ratio:
2.64x
P/S ratio:
0.12x
P/B ratio:
0.33x
Volume:
678.7K
Avg. volume:
561.8K
1-year change:
-42.83%
Market cap:
$3.9B
Revenue:
$33.5B
EPS (TTM):
$1.18
Period Ending 2020-03-31 2021-03-31 2022-03-31 2023-03-31 2024-03-31
Revenue $31.6B $27.2B $27.8B $28.3B $33.5B
Revenue Growth (YoY) -1.83% -13.86% 2.24% 1.96% 18.05%
 
Cost of Revenues $24.7B $21.4B $21.7B $22.4B $26.3B
Gross Profit $6.9B $5.8B $6.1B $5.9B $7.2B
Gross Profit Margin 21.77% 21.29% 22.04% 20.95% 21.52%
 
R&D Expenses -- -- -- -- --
Selling, General & Admin -- -- -- -- --
Other Inc / (Exp) -- -- -- -- --
Operating Expenses $6.5B $5.7B $5.2B $4.9B $5.5B
Operating Income $401.2M $83.2M $928.4M $1.1B $1.7B
 
Net Interest Expenses $7.9M $47.6M $31.3M -- --
EBT. Incl. Unusual Items $453.4M $20.8M $1B $1.3B $2.1B
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense $323.7M $323.1M $267.7M $190.6M $616.1M
Net Income to Company $453.4M $20.8M $1B $1.3B $2.1B
 
Minority Interest in Earnings -$18.2M $3.8M -$7M -$10.6M -$11.9M
Net Income to Common Excl Extra Items $111.6M -$298.6M $726.5M $1.1B $1.4B
 
Basic EPS (Cont. Ops) $0.09 -$0.24 $0.58 $0.84 $1.14
Diluted EPS (Cont. Ops) $0.09 -$0.24 $0.58 $0.84 $1.14
Weighted Average Basic Share $1.3B $1.3B $1.3B $1.3B $1.3B
Weighted Average Diluted Share $1.3B $1.3B $1.3B $1.3B $1.3B
 
EBITDA $1.4B $943.3M $1.9B $2.1B $2.9B
EBIT $509.9M $96.6M $1.1B $1.3B $2.1B
 
Revenue (Reported) $31.6B $27.2B $27.8B $28.3B $33.5B
Operating Income (Reported) $401.2M $83.2M $928.4M $1.1B $1.7B
Operating Income (Adjusted) $509.9M $96.6M $1.1B $1.3B $2.1B
Period Ending 2020-06-30 2021-06-30 2022-06-30 2023-06-30 2024-06-30
Revenue $3.5B $7.3B $4.8B $8B $7.7B
Revenue Growth (YoY) -54.68% 109.69% -35.1% 66.91% -2.73%
 
Cost of Revenues $2.8B $5.7B $3.8B $6.4B $6.1B
Gross Profit $684.3M $1.7B $1B $1.6B $1.6B
Gross Profit Margin 19.55% 22.53% 21.2% 19.83% 21.32%
 
R&D Expenses -- -- -- -- --
Selling, General & Admin -- -- -- -- --
Other Inc / (Exp) -- -- -- -- --
Operating Expenses $1.1B $1.4B $1.2B $1.4B $1.3B
Operating Income -$420.7M $238.5M -$150.7M $218.8M $323M
 
Net Interest Expenses $10.9M $9.1M $432.2K -- --
EBT. Incl. Unusual Items -$583.3M $232.3M $156.6M $460.3M $507.9M
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense $47.2M $125.2M $39.2M $185.9M $185.1M
Net Income to Company -$583.3M $232.3M $156.6M $460.3M --
 
Minority Interest in Earnings $10.8M -$3.1M -$1.6M -$2.9M -$3.3M
Net Income to Common Excl Extra Items -$619.7M $103.9M $115.7M $271.4M $319.5M
 
Basic EPS (Cont. Ops) -$0.49 $0.08 $0.09 $0.22 $0.25
Diluted EPS (Cont. Ops) -$0.49 $0.08 $0.09 $0.22 $0.25
Weighted Average Basic Share $1.3B $1.3B $1.3B $1.3B $1.3B
Weighted Average Diluted Share $1.3B $1.3B $1.3B $1.3B $1.3B
 
EBITDA -$350.6M $451M $363.8M $674.5M $709.8M
EBIT -$563.2M $247.7M $169.9M $474.3M $523.8M
 
Revenue (Reported) $3.5B $7.3B $4.8B $8B $7.7B
Operating Income (Reported) -$420.7M $238.5M -$150.7M $218.8M $323M
Operating Income (Adjusted) -$563.2M $247.7M $169.9M $474.3M $523.8M
Period Ending 2020-06-30 2021-06-30 2022-06-30 2023-06-30 2024-06-30
Revenue $27.3B $31.1B $25.2B $31.4B $33.2B
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues $21.4B $24.3B $19.7B $24.9B $25.9B
Gross Profit $5.9B $6.8B $5.5B $6.5B $7.2B
Gross Profit Margin -- -- -- -- --
 
R&D Expenses -- -- -- -- --
Selling, General & Admin -- -- -- -- --
Other Inc / (Exp) -- -- -- -- --
Operating Expenses $6B $6B $4.9B $5.1B $5.4B
Operating Income -$81.4M $752.2M $532.8M $1.4B $1.8B
 
Net Interest Expenses $16.2M $45.8M $22.8M -- --
EBT. Incl. Unusual Items -$206.6M $848.7M $913.1M $1.6B $2.1B
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense $341.2M $401.2M $180.7M $338.8M $620.2M
Net Income to Company -$208.5M $836.4M $925.5M $1.6B --
 
Minority Interest in Earnings -$6.9M -$10.2M -$5.5M -$11.8M -$12.3M
Net Income to Common Excl Extra Items -$554.7M $437.3M $726.8M $1.2B $1.5B
 
Basic EPS (Cont. Ops) -$0.44 $0.35 $0.58 $0.96 $1.18
Diluted EPS (Cont. Ops) -$0.44 $0.35 $0.58 $0.96 $1.18
Weighted Average Basic Share -- -- -- -- --
Weighted Average Diluted Share -- -- -- -- --
 
EBITDA $714.5M $1.8B $1.8B $2.4B $2.9B
EBIT -$143.6M $919.9M $971.5M $1.6B $2.2B
 
Revenue (Reported) $27.3B $31.1B $25.2B $31.4B $33.2B
Operating Income (Reported) -$81.4M $752.2M $532.8M $1.4B $1.8B
Operating Income (Adjusted) -$143.6M $919.9M $971.5M $1.6B $2.2B
Period Ending 2020-06-30 2021-06-30 2022-06-30 2023-06-30 2024-06-30
Revenue $3.5B $7.3B $4.8B $8B $7.7B
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues $2.8B $5.7B $3.8B $6.4B $6.1B
Gross Profit $684.3M $1.7B $1B $1.6B $1.6B
Gross Profit Margin -- -- -- -- --
 
R&D Expenses -- -- -- -- --
Selling, General & Admin -- -- -- -- --
Other Inc / (Exp) -- -- -- -- --
Operating Expenses $1.1B $1.4B $1.2B $1.4B $1.3B
Operating Income -$420.7M $238.5M -$150.7M $218.8M $323M
 
Net Interest Expenses $10.9M $9.1M $432.2K -- --
EBT. Incl. Unusual Items -$583.3M $232.3M $156.6M $460.3M $507.9M
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense $47.2M $125.2M $39.2M $185.9M $185.1M
Net Income to Company -$583.3M $232.3M $156.6M $460.3M --
 
Minority Interest in Earnings $10.8M -$3.1M -$1.6M -$2.9M -$3.3M
Net Income to Common Excl Extra Items -$619.7M $103.9M $115.7M $271.4M $319.5M
 
Basic EPS (Cont. Ops) -$0.49 $0.08 $0.09 $0.22 $0.25
Diluted EPS (Cont. Ops) -$0.49 $0.08 $0.09 $0.22 $0.25
Weighted Average Basic Share $1.3B $1.3B $1.3B $1.3B $1.3B
Weighted Average Diluted Share $1.3B $1.3B $1.3B $1.3B $1.3B
 
EBITDA -$350.6M $451M $363.8M $674.5M $709.8M
EBIT -$563.2M $247.7M $169.9M $474.3M $523.8M
 
Revenue (Reported) $3.5B $7.3B $4.8B $8B $7.7B
Operating Income (Reported) -$420.7M $238.5M -$150.7M $218.8M $323M
Operating Income (Adjusted) -$563.2M $247.7M $169.9M $474.3M $523.8M
Period Ending 2020-03-31 2021-03-31 2022-03-31 2023-03-31 2024-03-31
Cash and Equivalents $4.8B $5.4B $5.5B $4.7B $5.4B
Short Term Investments $434.9M $1.3B $581.7M $667.9M $687.1M
Accounts Receivable, Net $1.6B $1.5B $1.2B $1.3B $1.1B
Inventory $4.1B $3.9B $3.3B $5B $4.5B
Prepaid Expenses -- -- -- -- --
Other Current Assets $1.3B $1.4B $1.4B $1.3B $1.5B
Total Current Assets $12.2B $13.5B $11.9B $12.9B $13.2B
 
Property Plant And Equipment $9.9B $9.7B $9.4B $8.7B $7.9B
Long-Term Investments -- -- -- -- --
Goodwill -- -- -- -- --
Other Intangibles $371M $389M $396.2M $409.9M $414.4M
Other Long-Term Assets $407.5M $349.2M $392.5M $280.4M $449.7M
Total Assets $25.8B $26.4B $24.3B $24.5B $25.1B
 
Accounts Payable $3.4B $3.3B $2.8B $3.6B $2.9B
Accrued Expenses -- -- -- -- --
Current Portion Of Long-Term Debt -- -- -- -- --
Current Portion Of Capital Lease Obligations $41.5M $40.6M $36M $51.4M $47.8M
Other Current Liabilities $411.7M $495.5M $929.8M $928.5M $838.6M
Total Current Liabilities $8.6B $7.3B $7.4B $9.5B $9.3B
 
Long-Term Debt $4.1B $6.5B $4.8B $3B $2.7B
Capital Leases -- -- -- -- --
Total Liabilities $14.6B $15.6B $13.5B $13.5B $13.4B
 
Common Stock $2.6B $2.6B $2.3B $2.1B $1.9B
Other Common Equity Adj -- -- -- -- --
Common Equity $10.9B $10.7B $10.7B $10.8B $11.5B
Total Preferred Equity -- -- -- -- --
Minority Interest, Total $283.2M $124.4M $123.9M $125.5M $127.7M
Total Equity $11.2B $10.8B $10.8B $10.9B $11.6B
 
Total Liabilities and Equity $25.8B $26.4B $24.3B $24.5B $25.1B
Cash and Short Terms $5.3B $6.7B $6.1B $5.4B $6.1B
Total Debt $5.5B $6.7B $5.4B $4.5B $3.6B
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Cash and Equivalents $6.8B $6.2B $5B $5B $5.8B
Short Term Investments $1.1B $1.1B $415.3M $261.1M $1.3B
Accounts Receivable, Net $1.4B $1B $1.1B $1.1B $1B
Inventory $4.3B $3.3B $3.9B $4.8B $5.1B
Prepaid Expenses -- -- -- -- --
Other Current Assets $1.4B $1.2B $1.3B $1.3B $1.5B
Total Current Assets $15B $12.8B $11.7B $12.5B $14.7B
 
Property Plant And Equipment $9.9B $9.7B $8.1B $7.9B $8.4B
Long-Term Investments -- -- -- -- --
Goodwill -- -- -- -- --
Other Intangibles -- -- -- -- --
Other Long-Term Assets $1.1B $835.2M $642.5M $570.9M $960.7M
Total Assets $28.3B $25.7B $22.4B $23.5B $27B
 
Accounts Payable $3.4B $2B $2.9B $3.2B $3.2B
Accrued Expenses -- -- -- -- --
Current Portion Of Long-Term Debt -- -- -- -- --
Current Portion Of Capital Lease Obligations $41.8M $37.7M $29.3M $47.3M $50M
Other Current Liabilities $691.3M $889.7M $1.1B $1.1B $1.2B
Total Current Liabilities $9.1B $6.9B $8.2B $8.7B $9.7B
 
Long-Term Debt $6.9B $6.2B $3B $2.6B $3.4B
Capital Leases -- -- -- -- --
Total Liabilities $18B $14.8B $12.5B $12.7B $14.9B
 
Common Stock $2.7B $2.5B $2B $1.9B $2B
Other Common Equity Adj -- -- -- -- --
Common Equity -- -- -- -- --
Total Preferred Equity -- -- -- -- --
Minority Interest, Total $273.9M $124.6M $112.9M $121.2M $147.1M
Total Equity $10.4B $10.9B $9.9B $10.8B $12.1B
 
Total Liabilities and Equity $28.3B $25.7B $22.4B $23.5B $27B
Cash and Short Terms $7.9B $7.3B $5.4B $5.2B $7.1B
Total Debt $8.9B $7.5B $4.9B $3.6B --
Period Ending 2020-03-31 2021-03-31 2022-03-31 2023-03-31 2024-03-31
Net Income to Stockholders $453.4M $20.8M $1B $1.3B $2.1B
Depreciation & Amoritzation $848.9M $846.8M $804.2M $784.6M $785.5M
Stock-Based Compensation -- -- -- -- --
Change in Accounts Receivable $168.7M $54.6M -$159.7M -$129.7M $93.1M
Change in Inventories -$468.1M $283.5M $689.5M -$1.9B $296.3M
Cash From Operations $320.5M $1.1B $1.7B $1B $2.9B
 
Capital Expenditures $1.1B $811.6M $1.2B $734.1M $798.6M
Cash Acquisitions -- -- -- -- --
Cash From Investing -$1.2B -$743.9M -$1.2B -$736.3M -$1.2B
 
Dividends Paid (Ex Special Dividend) -$202.8M -$118.8M -- -$186.6M -$218.3M
Special Dividend Paid
Long-Term Debt Issued $469.8M $2.7B $629M $35.6M $851.9M
Long-Term Debt Repaid -$442.1M -$344.7M -$1.3B -$470.6M -$1.4B
Repurchase of Common Stock -- -- -- -- --
Other Financing Activities -- -$168.2M -- -- --
Cash From Financing -$223.3M $937.2M -$769.7M -$665.5M -$587M
 
Beginning Cash (CF) $6.5B $5.4B $6.6B $5.5B $5B
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions -$1.1B $1.3B -$298.3M -$384.1M $1.1B
Ending Cash (CF) $5.2B $7B $6.6B $5.3B $6.4B
 
Levered Free Cash Flow -$805.3M $320.9M $443.6M $283.6M $2.1B
Period Ending 2020-03-31 2021-03-31 2022-03-31 2023-03-31 2024-03-31
Net Income to Stockholders $13.7M $542.7M $553.5M $390.9M $473.6M
Depreciation & Amoritzation $214.5M $200.7M $225.5M $227.2M $211.3M
Stock-Based Compensation -- -- -- -- --
Change in Accounts Receivable $138M -$191.7M $17.7M -$303.5M -$99.4M
Change in Inventories $135.6M $516.5M $451.3M -$375M $545.3M
Cash From Operations $639.8M $1.5B $1.8B $664.8M $1.5B
 
Capital Expenditures $224.2M $214.3M $424.7M $213.4M $227.3M
Cash Acquisitions -- -- -- -- --
Cash From Investing -$212M -$174M -$421.2M -$227.6M -$641.9M
 
Dividends Paid (Ex Special Dividend) -$96.6K $1.8M -- -$7.9M -$5M
Special Dividend Paid -- -- -- -- --
Long-Term Debt Issued $223.8K -$37.6M $7.8M $3.6M $357.5M
Long-Term Debt Repaid -$89.6M -$113.3M -$677.9M -$231.7M -$113.3M
Repurchase of Common Stock -- -- -- -- --
Other Financing Activities -- $2.5M -- -- --
Cash From Financing -$279M -$1.6B -$1.9B -$776M $194.4M
 
Beginning Cash (CF) $5.2B $7.1B $6.8B $5.4B $5B
Foreign Exchange Rate Adjustment -$157M $197.9M $249.8M $44.1M $174.6M
Additions / Reductions $148.8M -$286.8M -$491.8M -$338.7M $1B
Ending Cash (CF) $5.2B $7B $6.6B $5.3B $6.4B
 
Levered Free Cash Flow $415.6M $1.3B $1.4B $451.4M $1.3B
Period Ending 2020-06-30 2021-06-30 2022-06-30 2023-06-30 2024-06-30
Net Income to Stockholders -$208.5M $836.4M $925.5M $1.6B --
Depreciation & Amoritzation $858.1M $837.4M $794.8M $790.9M --
Stock-Based Compensation -- -- -- -- --
Change in Accounts Receivable $533M -$652.8M $187.4M -$24.4M --
Change in Inventories $27.4M $135.9M -$375.1M -$994.8M --
Cash From Operations -$867.3M $2.5B $458.7M $2.2B $2.9B
 
Capital Expenditures $1000M $874.5M $1.2B $696.4M $587.5M
Cash Acquisitions -- -- -- -- --
Cash From Investing -$1B -$805.4M -$1.2B -$697.4M --
 
Dividends Paid (Ex Special Dividend) -$205.3M -$1.8M -$97.2M -$204.2M -$103.5M
Special Dividend Paid
Long-Term Debt Issued $3.2B -- $629M $297.9M --
Long-Term Debt Repaid -$444.8M -$328.1M -$1.3B -$1.5B --
Repurchase of Common Stock -- -- -- -- --
Other Financing Activities -- -- -- -- --
Cash From Financing $3.5B -$1.5B -$891.8M -$2B --
 
Beginning Cash (CF) -- -- -- -- --
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions $1.6B $210.7M -$1.6B -$413.3M --
Ending Cash (CF) -- -- -- -- --
 
Levered Free Cash Flow -$1.9B $1.6B -$721.5M $1.6B --
Period Ending 2021-03-31 2022-03-31 2023-03-31 2024-03-31 2025-03-31
Net Income to Stockholders $20.8M $1B $1.3B $2.1B --
Depreciation & Amoritzation $846.8M $804.2M $784.6M $785.5M --
Stock-Based Compensation -- -- -- -- --
Change in Accounts Receivable $54.6M -$159.7M -$129.7M $93.1M --
Change in Inventories $283.5M $689.5M -$1.9B $296.3M --
Cash From Operations $1.1B $1.7B $1B $2.9B --
 
Capital Expenditures $811.6M $1.2B $734.1M $798.6M --
Cash Acquisitions -- -- -- -- --
Cash From Investing -$743.9M -$1.2B -$736.3M -$1.2B --
 
Dividends Paid (Ex Special Dividend) -$118.8M -- -$186.6M -$218.3M --
Special Dividend Paid -- -- -- -- --
Long-Term Debt Issued $2.7B $629M $35.6M $851.9M --
Long-Term Debt Repaid -$344.7M -$1.3B -$470.6M -$1.4B --
Repurchase of Common Stock -- -- -- -- --
Other Financing Activities -$168.2M -- -- -- --
Cash From Financing $937.2M -$769.7M -$665.5M -$587M --
 
Beginning Cash (CF) $27.7B $28.6B $22.4B $20.7B --
Foreign Exchange Rate Adjustment $285.4M $312.5M $213.9M $331.7M --
Additions / Reductions $1.3B -$298.3M -$384.1M $1.1B --
Ending Cash (CF) $29.4B $28.4B $22B $21.8B --
 
Levered Free Cash Flow $320.9M $443.6M $283.6M $2.1B --

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret
Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret

It’s not often that a company with the scale and…

Will Tyson Foods Stock Bounce Back?
Will Tyson Foods Stock Bounce Back?

Tyson Foods, Inc. (NYSE:TSN) is one of the biggest food…

Will Iovance Biotherapeutics Stock Bounce Back?
Will Iovance Biotherapeutics Stock Bounce Back?

Iovance Biotherapeutics (NASDAQ:IOVA) is a fledgling pharmaceutical company that specializes…

Stock Ideas

Buy
64
Is AAPL Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 42x

Buy
52
Is NVDA Stock a Buy?

Market Cap: $3.3T
P/E Ratio: 113x

Buy
55
Is MSFT Stock a Buy?

Market Cap: $3.2T
P/E Ratio: 37x

Alerts

Buy
61
QMCO alert for Dec 21

Quantum [QMCO] is up 26.28% over the past day.

Sell
46
NUKK alert for Dec 21

Nukkleus [NUKK] is down 22.94% over the past day.

Sell
1
IIPR alert for Dec 21

Innovative Industrial Properties [IIPR] is down 22.7% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock